AUS vs IND: Nitish Kumar Reddy talked about his fandom for Virat Kohli. Reddy was at the non-striker's end when Kohli scored a century in the series opener at the Optus Stadium in Perth. Listen to ...

Ex-Andhra Pradesh Chief Minister Jagan Reddy has been accused of illegally acquiring 41.12 per cent of shares in Kakinada Seaport and 48.74 per cent in Kakinada Special Export Zone, for Rs 500 cr ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Raghu Ram explained his departure from Roadies after 11 years, citing pressure to lose his authenticity by constantly being told to scream at participants. He shared that the show’s demands ...

Raghu Ram has been through a lot, both personally and professionally. Despite this, his will to try new things and reinvent himself is inspiring. For the unversed, Raghu rose to massive fame with his ...

Reflecting on his tenure, Raghu Ram explained how his on-screen persona wasn’t a calculated move to gain popularity. Raghu Ram quit Roadies in 2014 after 11 years of being one of the main judges on ...

Ram Gopal Varma and Sandeep Reddy Vanga had a candid chat, where Varma challenged Vanga on his filmmaking abilities, particularly about making Baahubali. Varma teased Vanga for his diplomatic ...

Raghu Ram, former judge of Roadies, recently talked about his time on the show and explained the reason behind his tough persona and why he left. Known for his intense style, Raghu clarified that his ...

In 2023, Dr Reddy's entered into a license and commercialisation agreement with Shanghai Junshi Biosciences Co Ltd for Toripalimab. Under this agreement, Dr Reddy's obtained exclusive rights to ...

Former Roadies judge Raghu Ram shared why he left the show after six seasons, citing creative interference. He explained how honesty made the show relatable and shared insights into its selection ...

Dr. Reddy's Laboratories Ltd., along with its subsidiaries, announced the launch of Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma ...